Figure 1 In the emulated target trial, treatment strategies were defined as initiation of a GLP-1 RA or initiation of a DPP-4i at baseline
His physical fitness assessments showed slow gaits (6 m walk test of 8 seconds) and reduced muscle endurance (5 times sit to stand of 14 seconds), and the 6-minute walk test was 530 m with a recovery heart rate at 1 minute of 102 beats per minute
Immunostaining intensity was assessed quantitatively by immunohistomorphometry using ImageJ software (National Institutes of Health, Bethesda, MD), as described previously[48]
Cayetano tampoco quiere dar su apellido
Susan Spratt, an endocrinologist and senior medical director for the Population Health Management Office at Duke Health in North Carolina, said that although Zepbound provided more weight loss than Wegovy, both drugs are highly effective
Most insurance plans dont cover FDA-approved GLP-1 weight loss medications unless the individual has a qualifying diagnosis like type 2 diabetes or severe obesity